Rovida Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
WA
Rovida Advisors's JNJ Position: Q1 2022 in Review
Rovida Advisors sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 238,200 shares — an estimated $40.7M sold.
Rovida Advisors first reported a position in JNJ in Q4 2016 and held it in 20 quarters. The position peaked at $40.7M in Q4 2021. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.
- Rovida Advisors reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
- Rovida Advisors sold 238,200 Johnson & Johnson shares in Q1 2022, an estimated $40.7M.
- Rovida Advisors first reported a position in Johnson & Johnson in Q4 2016 and held it in 20 quarters.
- Rovida Advisors's Johnson & Johnson position peaked at $40.7M in Q4 2021.
- 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.
Based on Rovida Advisors's 13F filing for Q1 2022, filed 10 May 2022.